|07-27-2018 02:11 PM CET - Health & Medicine||
Global Vocal Biomarker Market: Size, Industry Player (IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, Beyond Verbal) Segmentation, Analysis and Forecast till 2027
Press release from: Fact.MR
Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth of Vocal Biomarker Market. The study is titled as “Vocal Biomarker Market Forecast, Trend Analysis & Competition Tracking: Global Review 2018 to 2027”, which deeply analyses the global market trends, with historical data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2018-2027. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the Global Vocal Biomarker Market.
According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments. Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.
Request For Sample Report @ www.factmr.com/connectus/sample?flag=S&rep_id=719
Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.
Detailed Assessment on Vocal Biomarker Market
Fact.MR has recently published a new report on the global vocal biomarker market, which offers accurate forecasts on the market for the period between 2018 and 2027. This report is a definite source of information that imparts intelligence on recent market dynamics, industry trends, potential markets, technology developments & advancements, and product innovation coupled with extensive regional market coverage.
A comprehensive data analysis on the global vocal biomarker market is delivered in the report, in order to help the clients in gaining a competitive edge and attracting potential customers. The report further aid in better understanding of the industry structure, and offers evaluations on the competition intensity attractiveness. Business strategists can leverage the intelligence offered in the report regarding latest opportunities and trends impacting the market expansion to make fact-based decisions for their businesses.
Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success
Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.
CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance. CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.
Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend
Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.
Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders. Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.
Browse Full Report with TOC @ www.factmr.com/report/719/vocal-biomarker-market
Vocal Biomarkers Reforming Healthcare Diagnostics
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as vocal biomarker, by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
These vocal biomarkers are deemed to have immense potential in diagnosing disease based on vocal cues. As part of ongoing breakthroughs, a group of researchers from the New York University Langone Medical Center is developing a machine learning-based artificial intelligence (AI) system that would be capable of analyzing various voice characteristics that include rhythm, tone, and pitch from patients.
Remote health monitoring potential of vocal biomarkers is also gaining high interest among researchers worldwide, For example, Beyond Verbal and Mayo Clinic have collaborated for discovering vocal patterns of patients suffering from coronary artery disease. A key concept backing the development is the impact of hardening of arteries on speech production. With advancements in technology, vocal biomarkers will soon be able to diagnose various diseases including certain cancers, Parkinson’s disease, and heart conditions.
North America Vocal Biomarker Market: Driven by Government Agencies’ Tie-ups with Voice-Related Companies
Robust healthcare infrastructure, and presence of well-funded research organizations equipped with cutting-edge technologies in North America have made the region a lucrative breeding place for vocal biomarkers. Tie-ups of the U.S. government agencies with voice-based companies and analysis researchers is a primary demand determinant for vocal biomarkers in the region across areas such as geriatrics and war-induced trauma. For example, the U.S. Army entered into a collaboration with researchers from MIT for developing voice-based detection system to diagnose brain injuries.
Fact.MR’s report foresees the global market for vocal biomarker to reflect a staggering expansion in the period of forecast, 2018 to 2027. Over US$ 390 Mn worth of vocal biomarkers are envisaged to be sold across the globe by 2027-end.
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market Research Reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
This release was published on openPR.
News-ID: 1150284 • Views: 214More releases